Patent · US Active

Methods and compositions for treating disorders

US10064963B2 · kind B2 · utility

0Cited by

0References

8Claims

0Family size

Assignee

Pieris Pharmaceuticals GmbH · DE

Inventors

Shane Olwill · Freising, DE
Hendrik Gille · Berlin, DE
Laurent Audoly · Mahwah, US
Marlon Hinner · Freising, DE
Elisabeth De Vries · Groningen, NL
Anton G. T. Terwisscha Van Scheltinga · Groningen, NL

Key dates

Filing date	Jan 7, 2013
Grant date	Sep 4, 2018
Priority date	—
Expiry date	May 18, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/70
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to a method of treating, ameliorating or preventing a disorder by blocking the signaling pathway of c-Met, wherein said method comprises the step of administering a therapeutically effective amount of a composition to a subject in need thereof, which composition contains a lipocalin mutein or a fragment or a variant thereof. In addition, the present disclosure relates to a diagnostic composition suitable for use in, e.g., an immuno-imaging technique to detect the presence of c-Met as well as the uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.